Peptides in 2026—Why Your Supplier Matters
Peptides have moved from “interesting biomolecules” to core tools across drug discovery, diagnostics, delivery science, and biomedical method development. In 2026, the headline is not just “more peptides,” but better peptide engineering: improved design, more realistic predictive modeling, stronger delivery concepts, and accelerating work in targeted conjugates and macrocyclic formats. At the same time, the […]
